Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-04-21 07:41:11 ET · period of report 2026-04-20 · accession 0001636178-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-04-21 07:41 | 2026-04-20 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $135.42 | +10.0K | 28.9K | +53% | +$1.35M |
| DMT | 2026-04-21 07:41 | 2026-04-20 | UTHR | EDGEMOND JAMES | CFO AND Treas | S - Sale+OE | $577.86 | -10.0K | 18.9K | -35% | -$5.78M |
| DT | 2026-04-21 07:41 | 2026-04-20 | UTHR | EDGEMOND JAMES | CFO AND Treas | M - OptEx | $0.00 | -10.0K | 72.5K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-20 | M | A | 10,000 | $135.42 | 28,876 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |
| 2 | Common | Common Stock | 2026-04-20 | S | D | 880 | $572.33 | 27,996 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $571.79 to $572.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-04-20 | S | D | 1,543 | $573.45 | 26,453 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $572.86 to $573.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-04-20 | S | D | 442 | $574.09 | 26,011 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $573.90 to $574.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-04-20 | S | D | 1,010 | $575.41 | 25,001 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $574.92 to $575.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-04-20 | S | D | 1,398 | $576.37 | 23,603 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $575.92 to $576.91. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-04-20 | S | D | 687 | $577.27 | 22,916 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $576.94 to $577.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2026-04-20 | S | D | 500 | $578.90 | 22,416 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F8) This transaction was executed in multiple trades at prices ranging from $578.26 to $579.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2026-04-20 | S | D | 340 | $579.86 | 22,076 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F9) This transaction was executed in multiple trades at prices ranging from $579.27 to $580.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2026-04-20 | S | D | 488 | $581.66 | 21,588 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F10) This transaction was executed in multiple trades at prices ranging from $581.01 to $582.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Common | Common Stock | 2026-04-20 | S | D | 983 | $582.47 | 20,605 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F11) This transaction was executed in multiple trades at prices ranging from $582.02 to $583.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 12 | Common | Common Stock | 2026-04-20 | S | D | 1,009 | $583.55 | 19,596 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F12) This transaction was executed in multiple trades at prices ranging from $583.035 to $584.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 13 | Common | Common Stock | 2026-04-20 | S | D | 482 | $584.49 | 19,114 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F13) This transaction was executed in multiple trades at prices ranging from $584.05 to $585.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 14 | Common | Common Stock | 2026-04-20 | S | D | 238 | $585.36 | 18,876 | D | — | — | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. (F14) This transaction was executed in multiple trades at prices ranging from $585.09 to $585.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 15 | Derivative | Stock Option | 2026-04-20 | M | D | 10,000 | $0.00 | 72,500 | D | $135.42 · 2023-03-15 to 2027-03-15 | 10,000 Common Stock | (F1) This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025. |